Clinical trial ongoing at the Institute:
- Mitochondriopathies register: prospective follow-up of a cohort of adult patients with mitochondrial diseases (observational study)
- REN001-201 / STRIDE: A double-blind, placebo-controlled study to evaluate the efficacy and safety of 24 weeks treatment with REN001 in patients with primary mitochondrialmyopathy (PMM)
- REN001-202: An open-label, multi-centre study to evaluate the long-term safety and tolerability of REN001 in subjects with primary mitochondrial myopathy (PMM)
Acronym |
Mitochondriopathies register |
REN001-201 / STRIDE |
REN001-202 |
| Intervention | – | REN001 | REN001 |
| Principal investigators |
Pascal Laforêt | Tanya Stojkovic | Tanya Stojkovic |
| Sponsor | Institut de Myologie | Reneo | Reneo |
| Study status | Ongoing | Ongoing | Ongoing |
| Recruitment status | Ongoing | Completed | Ongoing |
| Population | Adult | Adult | Adult |
| Contact | n.benammar@institut-myologie.org | essais-adultes@institut-myologie.org | essais-adultes@institut-myologie.org |
| + infos on clinicaltrials.gov | + infos on clinicaltrials.gov |
